Imuran and Pyoderma gangrenosum - a phase IV clinical study of FDA data

Summary:

Pyoderma gangrenosum is reported as a side effect among people who take Imuran (azathioprine), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Inflectra, and have Arthritis enteropathic.

The phase IV clinical study analyzes which people have Pyoderma gangrenosum when taking Imuran. It is created by eHealthMe based on reports of 34,190 people who have side effects when taking Imuran from the FDA, and is updated regularly.

What is Imuran?

Imuran has active ingredients of azathioprine. It is often used in crohn's disease. eHealthMe is studying from 34,915 Imuran users. Check the latest studies of Imuran.

What is Pyoderma gangrenosum?

Pyoderma gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance) is found to be associated with 304 drugs and 348 conditions by eHealthMe. Check the latest studies of Pyoderma gangrenosum.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

34,190 people reported to have side effects when taking Imuran.
Among them, 149 people (0.44%) have Pyoderma gangrenosum.

Could Imuran cause Pyoderma gangrenosum?

Among these 149 people:

How long have people been on Imuran when they have Pyoderma gangrenosum? *

Click here to view more results

What is the gender of people who have Pyoderma gangrenosum when taking Imuran? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Imuran and have Pyoderma gangrenosum?

- Check whether Pyoderma gangrenosum is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Imuran:

Imuran (34,915 reports)

Pyoderma gangrenosum treatments and more:

Pyoderma gangrenosum (5,867 reports)

How severe was Pyoderma gangrenosum and when was it recovered:

Pyoderma gangrenosum in Imuran

Expand to all the drugs that have ingredients of azathioprine:

Pyoderma gangrenosum and drugs with ingredients of azathioprine (161 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Imuran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pyoderma gangrenosum:

Pyoderma gangrenosum (304 drugs)

Browse all the conditions that are associated with Pyoderma gangrenosum:

Pyoderma gangrenosum (348 conditions)

Related publications that referenced our studies

Almarshad HA, "Effect of ginger rhizome extract on lymphocytopenic guinea pig with azathioprine", African Journal of Pharmacy and Pharmacology, 2014 Nov .
Hania A, "Pyoderma Gangrenosum in a Patient With Systemic Lupus Erythematosus: Case Report", Journal of Medical Cases, 2014 Aug .
Almarshad HA, "Effect of ginger rhizome extract on lymphocytopenic guinea pig with azathioprine", African Journal of Pharmacy and Pharmacology, 2014 Nov .
Hania A, "Pyoderma Gangrenosum in a Patient With Systemic Lupus Erythematosus: Case Report", Journal of Medical Cases, 2014 Aug .

How the study uses the data?

The study uses data from the FDA. It is based on azathioprine (the active ingredients of Imuran) and Imuran (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.